The Zacks Analyst Blog Highlights Meta Platforms, Costco Wholesale, BlackRock, AT&T and Enterprise Products Partners





For Immediate Release

Chicago, IL – August 15, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Meta Platforms, Inc. META, Costco Wholesale Corp. COST, BlackRock, Inc. BLK, AT&T Inc. T and Enterprise Products Partners L.P. EPD.

Here are highlights from Monday’s Analyst Blog:

Top Research Reports for Meta Platforms, Costco and BlackRock

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including Meta Platforms, Inc. (META), Costco Wholesale Corp. (COST) and BlackRock, Inc. (BLK). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today's research reports here >>>

Meta Platforms shares have outperformed the Zacks Internet - Software industry over the past year (+65.6% vs. +2.8%). This reflects the market's appreciation for management's effective expense-control measures earlier this year and the more signs of stabilization in the digital ad market.




Meta continues to benefit from steady user growth across all regions, particularly Asia Pacific. Increased engagement for its offerings like Instagram, WhatsApp, Messenger and Facebook has been a major growth driver.

Meta Platform is leveraging AI to recommend Reels content, which is driving traffic on Instagram and Facebook. The Zacks analyst expects revenues to grow at a CAGR of 12.2% between 2022 and 2025. Advertising revenues are expected to witness a CAGR of 12.5% per our model estimate.

However, challenging macroeconomic conditions remain a headwind for Meta's advertising revenues, along with targeting and measurement headwinds due to Apple's iOS changes. Slow monetization of Reels, along with mounting operating losses at Reality Labs, are concerns.

(You can read the full research report on Meta Platforms here >>>)

Shares of Costco Wholesale have outperformed the Zacks Retail - Discount Stores industry over the past year (+4.4% vs. +0.6%) on the back of the company's consumer defensive attributes.

The discount retailer's key strengths are strategic investments, a customer-centric approach, merchandise initiatives, and an emphasis on membership growth. These factors have been helping it register decent sales and earnings numbers. This outlook reflects Costco's ability to navigate the challenging operating environment, generate solid sales, and register high membership renewal rates.

A favorable product mix, steady store traffic, pricing power and strong liquidity position should help Costco keep outperforming. While trading at a premium to its peers, its long-term growth prospects should help the stock see a solid upside.

(You can read the full research report on Costco Wholesale here >>>)

BlackRock shares have modestly underperformed the Zacks Financial - Investment Management industry over the past six months (-3.1% vs. -1.7%). Increasing expenses (mainly owing to higher administration costs) are expected to hurt profits to an extent. The Zacks analyst expects total non-interest expenses to increase 2.4% this year. The company's high dependence on overseas revenues makes us apprehensive.

However, BlackRock continues to restructure the equity business, which, along with strategic acquisitions, will likely keep supporting revenue growth, and help expand market share and footprints globally.

A solid AUM balance is expected to further support the top line. We project total revenues to witness a CAGR of 8% over the next three years ended 2025. BLK's capital deployment activities reflect a solid liquidity position.

(You can read the full research report on BlackRock here >>>)

Other noteworthy reports we are featuring today include AT&T Inc. and Enterprise Products Partners L.P.

Why Haven't You Looked at Zacks' Top Stocks?

Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.

See Stocks Free >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                                      

https://www.zacks.com                                                 

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Zacks Names "Single Best Pick to Double"



From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.



It’s credited with a “watershed medical breakthrough” and is developing a bustling pipeline of other projects that could make a world of difference for patients suffering from diseases involving the liver, lungs, and blood. This is a timely investment that you can catch while it emerges from its bear market lows.






It could rival or surpass other recent Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

AT&T Inc. (T) : Free Stock Analysis Report

BlackRock, Inc. (BLK) : Free Stock Analysis Report

Enterprise Products Partners L.P. (EPD) : Free Stock Analysis Report

Costco Wholesale Corporation (COST) : Free Stock Analysis Report

Meta Platforms, Inc. (META) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research





The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.




Post a Comment

0 Comments